Piramal Pharma Annual General Meeting
Piramal Pharma Ltd announces its 6th AGM on 30 July 2026 and releases the FY 2025‑26 Annual Report. Shareholders may view it via QR code or the website.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
35 announcements with these filters
Piramal Pharma Ltd announces its 6th AGM on 30 July 2026 and releases the FY 2025‑26 Annual Report. Shareholders may view it via QR code or the website.
Piramal Pharma allotted 21,00,000 equity shares at Rs. 10 each to its ESOP Trust. The issuance supports the company's employee incentive plan and increases paid-up capital to ₹2.10 Crore.
Piramal Pharma received permanent revocation of closure directions for its Dahej site from GPCB. Operations continue normally, ensuring sustained manufacturing stability and environmental compliance.
Piramal Pharma submitted its Annual Secretarial Compliance Report for the financial year 2025-26. The report confirms adherence to SEBI regulations with no adverse observations noted.
Piramal Pharma received an Establishment Inspection Report from the US FDA for its Telangana facility. The inspection is successfully closed, ensuring regulatory compliance and operational continuity.